The status of MSI-H/dMMR or CMS of CRC patients is highly significant for therapy option and prognosis prediction [76] .
← all excerpts
Impact of Cuproptosis-related markers on clinical status, tumor immune microenvironment and immunotherapy in colorectal cancer: A multi-omic analysis.
1
—
—